astragaloside a has been researched along with Neuroblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, C; Tang, B; Wang, L | 1 |
| Gao, GD; Li, LH; Qin, HZ; Wang, JL; Wu, L; Xia, Y; Yang, JD; Yao, LB; Zhang, J; Zhang, ZG | 1 |
2 other study(ies) available for astragaloside a and Neuroblastoma
| Article | Year |
|---|---|
Astragaloside IV mitigates cerebral ischaemia-reperfusion injury via inhibition of P62/Keap1/Nrf2 pathway-mediated ferroptosis.
Topics: Animals; Brain Ischemia; Ferroptosis; Humans; Kelch-Like ECH-Associated Protein 1; Neuroblastoma; NF-E2-Related Factor 2; Oxygen; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction; Stroke | 2023 |
Astragaloside IV prevents MPP⁺-induced SH-SY5Y cell death via the inhibition of Bax-mediated pathways and ROS production.
Topics: 1-Methyl-4-phenylpyridinium; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Line, Tumor; Cell Survival; Dopaminergic Neurons; Gene Expression Regulation; Humans; Neuroblastoma; Parkinson Disease; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Saponins; Triterpenes | 2012 |